Home
Conditions
Influenza, Human

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 84 recruiting studies

Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

NCT00319098

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Caen, France

GSK Investigational Site Lagord, France

View all 40 locations

View Trial Details

Completed

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

NCT01640691

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +5 more
Locations: National Cheng Kung University Hospital Tainan, Taiwan

View Trial Details

Completed

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects

NCT01356316

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Not specified

View Trial Details

Completed

The Safety and Immune Response to Influenza Vaccination in Pregnant Women

NCT01514708

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects

NCT01759654

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

NCT01755364

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Chang Gung Memorial Hospital at Linkuo Taoyuan, Taiwan

View Trial Details

Completed

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

NCT00545532

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Uni of Alabama At Birmingham; Division of Nephrology Birmingham, Alabama, United States

University of Alabama at Birmingham; Pediatric Nephrology Birmingham, Alabama, United States

Pacific Oaks Medical Group Beverly Hills, California, United States

Providence Clinical Research Burbank, California, United States

View all 208 locations

View Trial Details

Completed

Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

NCT02035696

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Site 116 Phoenix, Arizona, United States

Site 119 Tucson, Arizona, United States

Site 109 Little Rock, Arkansas, United States

Site 112 Long Beach, California, United States

View all 27 locations

View Trial Details

Completed

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years

NCT00719043

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Denver, Colorado, United States

GSK Investigational Site Chicago, Illinois, United States

GSK Investigational Site Metairie, Louisiana, United States

GSK Investigational Site Milford, Massachusetts, United States

View all 13 locations

View Trial Details

Completed

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

NCT00646152

Conditions: DNA Virus Infections, Ebola, Filoviridae Infections, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Influenza, Human

Influenza, Human trial results

Related conditions